Reduces Food Cravings Especially cravings for sweets and processed foods
By developing their own oral replacements, they are ensuring that even when the patents for Mounjaro expire in the 2030s, the company will already have moved the market to the next generation of superior therapies
The invisible transformation protects you
are co-founders of Ousia Pharma, a biotech company developing therapeutics for the treatment of obesity
There are specific circumstances in which professional advice is particularly important: Before starting any new supplement whilst enrolled in a clinical trial or taking a GLP-1 medicine, as this may affect trial validity or treatment safety If you have diabetes , as retatrutide has glucose-lowering properties and, if you are also taking insulin or a sulfonylurea, the risk of hypoglycaemia requires careful management If you have liver or kidney disease , since both NAD+ metabolism and retatrutide's glucagon-mediated actions involve hepatic pathways
Diabetes Obes Metab (2022) 24(2):28995